Journal article
Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome
Abstract
BACKGROUND: Children with Down syndrome (DS) have an elevated risk of developing acute leukemia, but little is known about treatment-related neuropsychological morbidity because they are systematically excluded from research in this area. The current study investigated neuropsychological outcomes in children with DS treated for acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) compared to children with DS with no history of …
Authors
Roncadin C; Hitzler J; Downie A; Montour‐Proulx I; Alyman C; Cairney E; Spiegler BJ
Journal
Pediatric Blood & Cancer, Vol. 62, No. 5, pp. 854–858
Publisher
Wiley
Publication Date
May 2015
DOI
10.1002/pbc.25362
ISSN
1545-5009
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdolescentAntineoplastic Combined Chemotherapy ProtocolsCase-Control StudiesChildChild, PreschoolCognitionDown SyndromeFemaleFollow-Up StudiesHumansInfantInfant, NewbornIntelligenceLanguage DevelopmentLeukemia, Myeloid, AcuteMaleNeoplasm StagingNervous System DiseasesNeuropsychological TestsPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisVisual Acuity